Oil Rallies Extend, Asset Sales Unlock Value, and Margin Pressure Hits AI Play

Crude strength powered another explosive move in a small-cap energy name, while a multibillion-dollar asset sale unlocked significant shareholder value. But the enthusiasm wasn’t universal, as margin compression and softer forward guidance weighed heavily on one high-profile AI-linked software stock.

Elite Trade Club and Alumni Ventures are teaming up this month only to give readers early access to high-growth startup opportunities, including some of today’s most exciting AI First, Deep Tech, Quantum Computing, and Space companies co-invested alongside top VC firms like Andreessen Horowitz (a16z), Bessemer, & Y Combinator.

You get:

Don’t miss your chance before access closes.

Join Alumni Ventures Syndicate Today

Wall Street fell as escalating tensions in the Middle East fueled concerns about higher oil prices and rising inflation, which could delay Federal Reserve rate cuts. Investors worried that a prolonged conflict could slow global economic growth, weighing on broader market sentiment despite some positive corporate earnings.

Blackstone Inc (NYSE: BX) just saw a surge of client withdrawals from its flagship private credit fund BCRED, one of the largest funds of its kind in the world.

Redemption requests came in well above normal levels, forcing Blackstone to raise its usual withdrawal cap and invest hundreds of millions of its own money into the fund to meet every request.

When a firm this powerful has to step in with its own capital, the signal is hard to ignore.

Trust Is the Product

Private credit has been one of the fastest-growing corners of finance over the past decade. Firms like Blackstone built massive funds by promising wealthy individuals access to returns that traditional markets could not match.

That pitch only works as long as clients believe the valuations are real and the exits are available.

You can have the best portfolio in the industry, but the moment clients start lining up to leave, perception becomes the only thing that matters.

The Industry Has a Credibility Problem

Blackstone is not the only firm feeling pressure. Smaller rivals have faced questions about transparency, valuations, and how redemptions are being handled.

A UK mortgage lender collapsed days earlier, adding fuel to broader concerns about hidden risks across private credit.

You can call this a temporary panic or an early warning sign. Either way, Blackstone just showed that even the giants are not immune when confidence wavers.

Theravance Biopharma (NASDAQ: TBPH)'s lead program just failed. The Phase 3 trial for ampreloxetine, a drug designed to treat a debilitating blood pressure condition in patients with multiple system atrophy, did not meet its primary endpoint. The company has decided to shut down the entire program.

Within hours of announcing the failure, Theravance revealed it is cutting 50% of its workforce, winding down its R&D function, and accelerating a strategic review that includes a potential sale of the company.

From Drug Company to Shell in One Move

Theravance is reducing costs by roughly 60% and essentially dismantling its research operations. What remains is a smaller organization focused on generating cash from existing royalty streams while advisors search for a buyer.

You do not often witness a company go from active drug developer to sale candidate in a single announcement. That speed tells the full story of how much was riding on this one trial. If your impression of Theravance was built around its pipeline, the company just erased that identity entirely.

The Clock Starts Now

The company has been working with an independent financial advisor on strategic alternatives since 2024. The failed trial removes the last reason to stay independent.

You can expect the sale process to move quickly now that the only question left is who buys what remains and at what price.

Last century, power was built in oil refineries.

Today, it’s built-in rare-earth processing.

While most investors focus on mining, the real leverage sits in the midstream step that turns raw materials into finished metals and magnets used across defense and advanced technology.

That capability is limited outside China.

One North America based processor is working to build an integrated domestic pathway from mining to finished magnets, with operations based on North American soil.

If execution continues and the market begins to recognize the strategic value of this supply chain, the stock could see meaningful upside.

Read the full breakdown.

Accenture plc (NYSE: ACN) just acquired the Connectivity division of Ziff Davis for $1.2 billion in cash, picking up Speedtest by Ookla, Downdetector, RootMetrics, and Ekahau. 

Accenture now owns the data layer that tells the world how well its networks actually work.

Consulting Meets Real-Time Data

Accenture already advises the world's largest telecom companies, governments, and enterprises on technology strategy. Adding network intelligence tools gives it something competitors do not have—proprietary, real-time performance data from billions of tests and reports worldwide.

You think about what a consulting firm can do when it owns the measurement tools and the advisory relationship simultaneously. The pitch to every telecom client just got significantly more powerful.

AI Needs Network Intelligence

Accenture is positioning these tools as essential to AI-driven network transformation. If your impression of Accenture is still PowerPoint decks and strategy reports, this acquisition adds a layer of proprietary technology that changes the value proposition entirely.

From Consulting to Platform

Accenture has been quietly evolving from a pure advisory business into something that owns data, tools, and intelligence. This deal accelerates that shift in a meaningful way.

You can hire any consulting firm for advice. Only one now owns the products that measure how the internet performs worldwide, and that distinction is worth a lot more than $1.2 billion over time

👉 Click here to get our closing report to your cell for free!

Battalion Oil Corp [BATL] $27.62 (+134.07%)

Battalion Oil surged for a second straight session after announcing a $15 million private placement to strengthen its balance sheet, as crude prices continued climbing on escalating Middle East supply risks.

Ziff Davis Inc [ZD] $41.46 (+48.02%)

Ziff Davis jumped after agreeing to sell its Connectivity division to Accenture for $1.2 billion in cash, unlocking significant shareholder value.

LendingTree Inc [TREE] $46.75 (+23.87%)

LendingTree climbed after reporting stronger-than-expected revenue growth and issuing upbeat guidance that outweighed a quarterly earnings miss.

Power Solutions International [PSIX] $60.91 (-28.97%)

Power Solutions plunged after reporting sharply lower gross margins and declining earnings, as production inefficiencies tied to its data center ramp-up overshadowed strong revenue growth.

Harrow Inc [HROW] $38.60 (-27.97%)

Harrow fell after missing quarterly earnings expectations, as weaker-than-anticipated profitability overshadowed modest revenue growth.

MongoDB Inc [MDB] $252.73 (-22.24%)

MongoDB sank after issuing first-quarter profit guidance below estimates and reporting slower growth in its Atlas cloud database segment.

Bloomberg is calling Elon Musk's upcoming SpaceX IPO "the biggest listing of ALL TIME."

But here's the thing - most investors will be locked out until AFTER it goes public.

Not you.

I've found a 'backdoor' that lets everyday Americans grab a pre-IPO stake in SpaceX right now.

Click Here for the FREE "SpaceX" Ticker

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.